🇺🇸 FDA
Pipeline program

Lifileucel

C-144-01

Phase 2 mab completed

Quick answer

Lifileucel for Metastatic Melanoma is a Phase 2 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Metastatic Melanoma
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials